Articles From: PetSmart, Inc. Acquisition By BC Partners, Inc. Is The Subject Of A Legal Investigation to Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting


2014/12/15
NEW YORK , Dec.
Sign-up for PetSmart, Inc. Acquisition By BC Partners, Inc. Is The Subject Of A Legal Investigation investment picks
2014/12/15
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of PetSmart, Inc. (“PetSmart”) (NasdaqGS: PETM) concerning the sale to BC Partners, Inc. Under the terms of the agreement, PetSmart shareholders will only receive $83.00 in cash for each share owned, which is less than a 7% premium over the closing price just before the deal was announced and virtually no premium over 52-week high.
Sign-up for PETSMART, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to BC Partners, Inc. investment picks
2014/12/31
Rigrodsky & Long, P.A.: Do you own shares of PetSmart, Inc. (NASDAQ GS: PETM )? Did you purchase any of your shares prior to December 15, 2014?
Sign-up for PETSMART, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2014/12/15
WILMINGTON, Del.
Sign-up for PETSMART, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
PetSmart, Inc .
Sign-up for PetSmart, Inc. to Host Third Quarter 2014 Earnings Conference Call investment picks
PetSmart Inc. (PETM) said Tuesday that third-quarter net income was $92.2 million, or 92 cents a share, up from the $92.2 million, or 88 cents a share, for the same period a year ago.
Sign-up for PetSmart's income comes in ahead of views; shares up investment picks
2014/12/16
http://media.marketwire.com/attachments/201411/291413_PetziConnectlogojpg.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1165223&ProfileId=051205&sourceType=1 SANTA CLARA, CA --
Sign-up for Petzila Selects Marvell's EZ-Connect(TM) to Power Their Latest Pet Technology, PetziConnect investment picks
2014/11/5
OR YEHUDA, Israel , November 5, 2014 /PRNewswire/ -- Magic Software Enterprises Ltd.
Sign-up for Petzl, Leading Manufacturer of Equipment for Sports and Work at Height, Selects Magic xpi Integration Platform for Business Process Automation investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987848001&sourceType=1 http://www.ccnmatthews.com/logos/20111129-peyto_200.jpg CALGARY, ALBERTA --
Sign-up for Peyto Exploration & Development Corp. Announces Management Team Additions and Confirms Dividends for First Quarter 2015 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979211001&sourceType=1 http://www.ccnmatthews.com/logos/20111129-peyto_200.jpg CALGARY, ALBERTA --
Sign-up for Peyto Exploration & Development Corp. Confirms Dividends for December 15, 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0984130001&sourceType=1 http://www.ccnmatthews.com/logos/20111129-peyto_200.jpg CALGARY, ALBERTA --
Sign-up for Peyto Exploration & Development Corp. Confirms Dividends for January 15, 2015 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978607001&sourceType=1 http://www.ccnmatthews.com/logos/20111129-peyto_200.jpg CALGARY, ALBERTA --
Sign-up for Peyto Reports Record Quarterly Results, 2015 Capital Budget, and Dividend Increase investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0976192001&sourceType=1 http://www.ccnmatthews.com/logos/20081029-pfb1.jpg CALGARY, ALBERTA --
Sign-up for PFB Corporation Announces Its Third Quarter Results for 2014 and Declares Regular Quarterly Dividend investment picks
2014/11/13
SAN DIEGO , Nov.
Sign-up for Pfenex Reports Third Quarter 2014 Results and Provides Business Update investment picks
2014/11/6
SAN DIEGO , Nov.
Sign-up for Pfenex To Report Third Quarter 2014 Results and Provide Business Update on Thursday, November 13, 2014 investment picks
2014/11/6
Convenience in the kitchen is important.
Sign-up for Pfister® REACT™ Touch-Free Kitchen Faucets Offer Purposeful Technology and Convenience in the Kitchen investment picks
2015/1/5
By Angela Chen Pfizer Inc. has acquired a controlling interest in privately held Redvax GmbH, a move that gives the increasingly vaccine-focused drug giant access to a potential vaccine against a herpes virus.
Sign-up for Pfizer Acquires Redvax for its Potential Herpes Vaccine investment picks
By Angela Chen Pfizer Inc. has acquired a controlling interest in privately held Redvax GmbH, a move that gives the increasingly vaccine-focused drug giant access to a potential vaccine against a herpes virus.
Sign-up for Pfizer acquires Redvax for its potential herpes vaccine investment picks
2015/1/5
Pfizer Inc. today announced that it has acquired a controlling interest in Redvax GmbH, a spin-off from Redbiotec AG, a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren.
Sign-up for Pfizer Acquires Redvax GmbH investment picks
2014/12/10
Nearly one out of every two (45.25%) American women will be menopausal or approaching menopause next year.
Sign-up for Pfizer and Brenda Strong Encourage Women to Change the Conversation on Sexual Health Post-Menopause investment picks
Pfizer Inc. (NYSE:PFE) today announced the publication of the detailed results from PALOMA-1, a randomized Phase 2 study of palbociclib in combination with letrozole versus letrozole alone, in The Lancet Oncology .
Sign-up for Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology investment picks
Pfizer Inc. (NYSE:PFE) today announced that it has completed the acquisition of Baxter International Inc.’s portfolio of marketed vaccines.
Sign-up for Pfizer Completes Acquisition of Baxter’s Marketed Vaccines investment picks
2014/10/23
The board of directors of Pfizer Inc. today declared a 26-cent fourth-quarter 2014 dividend on the company’s common stock, payable December 2, 2014, to shareholders of record at the close of business on November 7, 2014.
Sign-up for Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend investment picks
2014/12/15
The board of directors of Pfizer Inc. today declared a 28-cent first-quarter 2015 dividend on the company’s common stock, payable March 3, 2015, to shareholders of record at the close of business on February 6, 2015.
Sign-up for Pfizer Declares First-Quarter 2015 Dividend investment picks
By Tess Stynes Pfizer Inc. said it notified Pain Therapeutics Inc. that it is ending its agreement to develop and commercialize an investigational extended-release version of oxycodone.
Sign-up for Pfizer ends agreement to develop Remoxy investment picks
Pfizer Inc. (NYSE:PFE) announced today two strategic decisions to expand the company’s rare disease research and development activities through the establishment of a gene therapy platform to investigate potential treatments for patients.
Sign-up for Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform investment picks
Pfizer Inc. (NYSE:PFE) announced today that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, to jointly develop and commercialize MSB0010718C, an investigational anti-PD-L1 antibody currently in development by Merck KGaA as a potential treatment for multiple types of cancer.
Sign-up for Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate Presence in Immuno-Oncology investment picks
Pfizer Inc. announced today that it will present data for several of its marketed and investigational medicines for inflammatory and immunological conditions at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2014 Annual Meeting (November 14-19, Boston, Massachusetts). Twenty-one abstracts for XELJANZ ® (tofacitinib citrate) will be presented, including the six-year safety and efficacy analyses from long-term extension (LTE) studies and a summary of real-world patient experience, additional post-hoc analyses from the clinical development program, and health and economics outcomes research, adding to the substantial body of evidence for XELJANZ as an oral treatment option for moderate to severe rheumatoid arthritis (RA). Data will also be presented for several additional Pfizer assets, including PF-04236921, an investigational
Sign-up for Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: PetSmart, Inc. Acquisition By BC Partners, Inc. Is The Subject Of A Legal Investigation to Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent